Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-04-28

Clinical Trial Update: Topical Compound Tripterygium Wilfordii Hook F for Patients With Active Rheumatoid Arthritis [NA]

View source ↗

Summary

This document reports the completion of a clinical trial evaluating a topical Tripterygium wilfordii Hook F compound for rheumatoid arthritis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Topical Tripterygium wilfordii Hook F (Tripterygium wilfordii Hook F)

Snippet

Sponsor: Guang'anmen Hospital of China Academy of Chinese Medical Sciences | Conditions: Active Rheumatoid Arthritis | NA | Status: COMPLETED